Evelyn S. Dilsaver - May 27, 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Evelyn Dilsaver
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 05:31 PM
Previous filing
May 9, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award +274 274 May 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Award $0 +275 $0.00 275 May 27, 2022 Common Stock 275 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.
F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.
F3 Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
F4 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023.